Matches in Wikidata for { <http://www.wikidata.org/entity/Q94408222> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q94408222 description "article scientifique publié en 2017" @default.
- Q94408222 description "wetenschappelijk artikel" @default.
- Q94408222 description "наукова стаття" @default.
- Q94408222 name "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 name "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 type Item @default.
- Q94408222 label "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 label "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 prefLabel "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 prefLabel "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 P1433 Q94408222-D59205EF-D070-43E2-9AED-EFAA49947CEB @default.
- Q94408222 P1476 Q94408222-EA093E2D-D688-4231-B35B-8FEB3113B41A @default.
- Q94408222 P2093 Q94408222-0CF1D210-BA33-453B-8F4D-4D5FA79BAAA3 @default.
- Q94408222 P2093 Q94408222-23A234C6-558C-4779-A0E8-6BBD185E2606 @default.
- Q94408222 P2093 Q94408222-41871967-C29F-4EF6-9088-43921C8B903D @default.
- Q94408222 P2093 Q94408222-44D46359-2E0E-4588-8ADD-3F69BCDC2A5E @default.
- Q94408222 P2093 Q94408222-6716186A-5422-4030-BBA0-30963CE47093 @default.
- Q94408222 P2093 Q94408222-BA27C14D-0726-42B4-87EB-D4DF5D1DEBCA @default.
- Q94408222 P2093 Q94408222-C2E0B497-DB87-4EA7-BD34-27042D77EE3F @default.
- Q94408222 P304 Q94408222-14F4379C-F83D-47B4-8A13-68D6B7EC02AB @default.
- Q94408222 P31 Q94408222-7CFBA744-5B52-48DF-B4CA-07E78807680E @default.
- Q94408222 P356 Q94408222-D35F9C61-0A89-412A-B338-62C8CA1D5EAE @default.
- Q94408222 P433 Q94408222-F6456414-52B2-40B6-85AD-8314A523ADBD @default.
- Q94408222 P478 Q94408222-03FF54DF-B5D0-4F93-BBA7-AAAD58282DE0 @default.
- Q94408222 P50 Q94408222-B785125B-AE9C-4C83-A722-65F751EB19DF @default.
- Q94408222 P577 Q94408222-AA3E4392-5744-44C3-B4EF-63826931F036 @default.
- Q94408222 P921 Q94408222-31649062-41BC-4089-8BE2-9A85D44B6891 @default.
- Q94408222 P921 Q94408222-8F8BB8C8-AE32-4E8B-B0A9-05AFEBA3F3CE @default.
- Q94408222 P921 Q94408222-D8B53269-F66E-46B7-8BD0-68A293D19744 @default.
- Q94408222 P932 Q94408222-7DD603B3-60E5-4E70-8962-844C62B21CB7 @default.
- Q94408222 P356 NOX168.119 @default.
- Q94408222 P1433 Q15724471 @default.
- Q94408222 P1476 "ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA" @default.
- Q94408222 P2093 "Alireza Mohammadi" @default.
- Q94408222 P2093 "Cathy Brewer" @default.
- Q94408222 P2093 "David M Peereboom" @default.
- Q94408222 P2093 "Maksim Sinyuk" @default.
- Q94408222 P2093 "Manmeet Ahluwalia" @default.
- Q94408222 P2093 "Michael Vogelbaum" @default.
- Q94408222 P2093 "Tyler Alban" @default.
- Q94408222 P304 "vi31-vi31" @default.
- Q94408222 P31 Q13442814 @default.
- Q94408222 P356 "10.1093/NEUONC/NOX168.119" @default.
- Q94408222 P433 "Suppl 6" @default.
- Q94408222 P478 "19" @default.
- Q94408222 P50 Q88337055 @default.
- Q94408222 P577 "2017-11-06T00:00:00Z" @default.
- Q94408222 P921 Q282142 @default.
- Q94408222 P921 Q413299 @default.
- Q94408222 P921 Q420207 @default.
- Q94408222 P932 "5692853" @default.